Nolpaza Control (Pantoprazole)

Pantoprazole, the active ingredient in Nolpaza Control, is a proton pump inhibitor presented as an oral tablet for oral use. It reduces gastric acid production and is used to manage conditions such as gastro‑oesophageal reflux disease, erosive esophagitis and Zollinger‑Ellison syndrome.

GNH USA supplies Nolpaza Control as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, and procurement teams across global markets, ensuring quality, regulatory compliance and timely delivery. Our supply chain adheres to EU GMP standards and supports local import requirements.

Pantoprazole is a proton pump inhibitor used to manage acid‑related gastrointestinal conditions. - Gastro‑oesophageal reflux disease (GERD): reduces esophageal acid exposure and relieves heartburn and regurgitation. - Erosive esophagitis: promotes healing of acid‑induced esophageal lesions. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion caused by gastrin‑producing tumors. - Prevention of NSAID‑induced gastric ulcers: lowers ulcer risk in patients requiring long‑term NSAID therapy. - Helicobacter pylori eradication (as part of combination therapy): enhances bacterial clearance when used with antibiotics.

Common Side Effects: - Headache: mild, transient headache. - Diarrhea: loose stools, usually self‑limiting. - Nausea: occasional feeling of queasiness. - Abdominal pain: mild discomfort in the stomach area.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or difficulty breathing requiring immediate medical attention. - Low magnesium levels: muscle cramps, weakness, or irregular heartbeat. - Clostridioides difficile infection: severe diarrhea and abdominal pain that may occur with prolonged use.

Before initiating therapy, consider the following precautions: - Assess renal function: dose adjustment may be needed in severe impairment. - Monitor for infection: prolonged use can increase risk of Clostridioides difficile infection. - Avoid concomitant use with drugs that require gastric acidity for absorption. - Use with caution in pregnancy: safety not established; weigh benefits against potential risks. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Pantoprazole may interact with several medicines; review the following: Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect, potentially decreasing cardiovascular protection. - Atazanavir: decreased absorption of atazanavir, leading to sub‑therapeutic levels. - Methotrexate: increased methotrexate toxicity due to reduced renal clearance. Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR, requiring closer coagulation monitoring. - Digoxin: may raise serum digoxin concentrations, necessitating dose adjustment. - Iron supplements: reduced iron absorption; consider spacing administration times.